TrialAnnals of the rheumatic diseases2014

Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1.

J Sieper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.